Steve Schonfeld Schonfeld Strategic Advisors
Steve Schonfeld is the founder of Schonfeld Strategic Advisors, a multi-manager investment firm with roots in proprietary trading. Schonfeld allocates capital across quantitative and discretionary strategies with an emphasis on risk controls and diversification of return streams. The firm is a major name in the multi-strategy hedge fund landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AMC Entertainment Holdings
AMC
|
+$36.2M |
| 2 |
ATH
Athene Holding Ltd. Class A Common Shares
ATH
|
+$16.5M |
| 3 |
McDonald's
MCD
|
+$14.5M |
| 4 |
Sinclair Inc
SBGI
|
+$12.6M |
| 5 |
IBKC
IBERIABANK Corp
IBKC
|
+$11M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Independence Realty Trust
IRT
|
+$8.78M |
| 2 |
AbbVie
ABBV
|
+$8.19M |
| 3 |
Visa
V
|
+$8.05M |
| 4 |
CONE
CyrusOne Inc Common Stock
CONE
|
+$7.33M |
| 5 |
Keurig Dr Pepper
KDP
|
+$7.21M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 24.78% |
| 2 | Technology | 13.29% |
| 3 | Consumer Discretionary | 12.94% |
| 4 | Financials | 10.86% |
| 5 | Communication Services | 10.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
426
Matador Resources
MTDR
$7.08B
| $365K | 0.04% |
15,362
-6,148
| -29% | -$154K |
|
427
Deluxe
DLX
$1.11B
| $364K | 0.04% |
+5,046
| New | +$370K |
|
428
MSCI
MSCI
$41.5B
| $364K | 0.04% |
3,741
-3,406
| -48% | -$309K |
|
|
SPLS
429
DELISTED
Staples Inc
SPLS
| $364K | 0.04% |
+41,483
| New | +$374K |
|
430
Patterson-UTI
PTEN
$4.53B
| $363K | 0.04% |
+14,930
| New | +$403K |
|
431
Sally Beauty Holdings
SBH
$1.57B
| $362K | 0.04% |
+17,716
| New | +$405K |
|
|
KATE
432
DELISTED
Kate Spade & Company
KATE
| $362K | 0.04% |
15,578
-116,235
| -88% | -$2.43M |
|
433
Compass Minerals
CMP
$1.03B
| $360K | 0.04% |
5,306
+1,692
| +47% | +$129K |
|
434
Bankunited
BKU
$3.3B
| $359K | 0.04% |
+9,613
| New | +$366K |
|
|
EV
435
DELISTED
Eaton Vance Corp.
EV
| $356K | 0.04% |
+7,916
| New | +$351K |
|
436
Nucor
NUE
$55.3B
| $355K | 0.04% |
+5,944
| New | +$363K |
|
437
Sarepta Therapeutics
SRPT
$1.93B
| $355K | 0.04% |
11,972
+1,872
| +19% | +$57.9K |
|
|
LUMO
438
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
| $351K | 0.04% |
+1,615
| New | +$231K |
|
439
Zumiez
ZUMZ
$310M
| $350K | 0.04% |
19,155
+4,791
| +33% | +$93.8K |
|
440
Valero Energy
VLO
$100B
| $347K | 0.03% |
+5,224
| New | +$350K |
|
441
AptarGroup
ATR
$8.55B
| $346K | 0.03% |
+4,505
| New | +$336K |
|
442
Johnson & Johnson
JNJ
$657B
| $344K | 0.03% |
+2,762
| New | +$330K |
|
443
Dr. Reddy's Laboratories
RDY
$10.1B
| $341K | 0.03% |
+42,425
| New | +$366K |
|
|
AERI
444
DELISTED
Aerie Pharmaceuticals
AERI
| $340K | 0.03% |
7,498
-34,096
| -82% | -$1.52M |
|
445
D.R. Horton
DHI
$41.7B
| $336K | 0.03% |
+10,086
| New | +$313K |
|
446
NETGEAR
NTGR
$569M
| $334K | 0.03% |
+6,730
| New | +$367K |
|
447
Teradata
TDC
$2.56B
| $333K | 0.03% |
10,693
-2,122
| -17% | -$64.1K |
|
448
Yum China
YUMC
$16.6B
| $329K | 0.03% |
+12,085
| New | +$323K |
|
449
Lamb Weston
LW
$7.57B
| $328K | 0.03% |
+7,805
| New | +$308K |
|
450
Scholastic
SCHL
$753M
| $328K | 0.03% |
+7,712
| New | +$351K |
|
Similar funds
Steve Schonfeld's Q1 2017 Portfolio in Review
As of Q1 2017, Steve Schonfeld held 843 positions worth $998M, up 29% from $772M the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Steve Schonfeld deployed $186M of net new capital in Q1 2017, opening 316 new positions and adding to 131 existing holdings. Its largest new stake was AMC Entertainment Holdings: 113,380 shares worth $35.7M.
By sector, the portfolio is most concentrated in Healthcare at 25% of assets, up from 24% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was AbbVie, an estimated $8.19M trimmed.
- Steve Schonfeld's largest Q1 2017 buy was AMC Entertainment Holdings: 113,380 shares worth $35.7M.
- Steve Schonfeld added most to Athene Holding Ltd. Class A Common Shares in Q1 2017, an estimated $16.5M increase.
- Steve Schonfeld's biggest Q1 2017 reduction was AbbVie, cutting an estimated $8.19M.
- Steve Schonfeld fully exited Independence Realty Trust in Q1 2017, selling an estimated $8.78M.
- Steve Schonfeld's ten largest holdings make up 15% of its $998M portfolio in Q1 2017.
- Steve Schonfeld opened 316 new positions and closed 270 in Q1 2017.
- Steve Schonfeld's portfolio value rose 29% quarter-over-quarter to $998M.
Based on Schonfeld Strategic Advisors's 13F filing for Q1 2017, filed 15 May 2017.